Colossal And Anduril Start Editing Military Dog DNA

Warhound has secured $200 million to clone and genetically engineer dogs for the United States military. The startup is a joint venture involving Ben Lamm of Colossal Biosciences and Palmer Luckey of Anduril. The company aims to produce animals equipped with advanced gear to support defense operations.

Lamm told Wired that the team has started modifying genes from cell samples of donor dogs. These samples came from high-performing military, police, and first responder canines across the country. The breeds include Belgian Malinois, along with some Labradors and Shepherds. Scientists at Colossal will alter these genes before cloning the animals.

Initial research focuses on reducing the likelihood of health issues common to these breeds, such as hip dysplasia and specific cancers. Lamm suggested to TechCrunch that future genetic changes could improve speed, agility, and scent detection capabilities.

Anduril will provide the hardware and software for the dogs. The company will design protective equipment, including goggles, vests, and body armor. Warhound is not planning to create cyborg dogs at this stage. Instead, the focus is on tools that protect the animals during active duty.

The ownership structure places Colossal Biosciences as an equity holder, with Lamm serving on the board. Luckey is a partner but does not hold a stake in the startup. David Spirk, formerly of Palantir, serves as CEO.

The first batch of genetically engineered dogs is expected to be born in early 2027. These animals will undergo training for standard working dog roles, including bomb detection and search-and-rescue missions.